⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
prnewswire.com
JNJ
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
prnewswire.com
JNJ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ
accessnewswire.com
JNJ
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
FNB Harvest d'actions à revenu élevé annonce les distributions d’octobre 2026
businesswire.com
LLY
AMZN
MSFT
NVDA
COIN
PLTR
TSLA
META
AMD
AVGO
COST
GOOGL
NFLX
AAPL
HOOD
SOFI
BKNG
CRWD
JNJ
ORCL
CME
ENB
SHOP
SU
TEL
Global Teledermatology Market Size, Share, Trends, Growth and Forecast 2026-2035 | AI, Hybrid Care and DTC Models Fuel 14.10% CAGR to USD 60.96 Billion by 2035
globenewswire.com
KVUE
JNJ
TDOC
AMWL
Hyperhidrosis Market: Over 60% of Treated Axillary Patients in Japan Discontinue Therapy, Creating an Opening for Topical Pipeline | DelveInsight
prnewswire.com
ABBV
JNJ
LULU
Global Surgical Robots Market Size, Share, Trends, and Forecast 2026-2035 | AI-Powered Innovation Drives 16.50% CAGR and USD 59.55 Billion Opportunity by 2035
globenewswire.com
ISRG
JNJ
MDT
SN
ZBH
ASNS
Japan Geriatric Healthcare Products Market Size, Share, Growth, Trends, and Forecast 2025-2034 | Robotics and Homecare Innovation Drive 7.50% CAGR to USD 39.51 Billion
globenewswire.com
MMM
ABT
GEHC
TMO
JNJ
Beacon Biosignals Acquires Snap Diagnostics, Paving the Way for EEG-Enabled Home Sleep Testing in Every Care Setting
globenewswire.com
JNJ
BMY